In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Siri Helene Bertelsen BrandalDepartment of Breast Diagnostics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, 0379 Oslo, Norway.ORCID 0000-0001-7749-4481 Torgeir MoInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway.ORCID 0000-0001-6817-6625 Anne FangbergetDepartment of Oncologic Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, 0379 Oslo, Norway.
Line Brennhaug NilsenDepartment of Medical Physics, Division of Cancer Medicine, Oslo University Hospital, 0379 Oslo, Norway.
Oliver Marcel GeierDepartment of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, 0379 Oslo, Norway.ORCID 0000-0003-3919-7579 Hilde BjørndalDepartment of Oncologic Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, 0379 Oslo, Norway.ORCID 0000-0002-9987-4116 Marit Muri HolmenDepartment of Breast Diagnostics, Division of Radiology and Nuclear Medicine, Oslo University Hospital, 0379 Oslo, Norway.ORCID 0000-0003-2803-4117 Olav EngebråtenInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway.ORCID 0000-0002-0986-6957 Øystein GarredDepartment of Pathology, Division of Laboratory Medicine, Oslo University Hospital, 0424 Oslo, Norway.
Knut Håkon HoleInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway.ORCID 0000-0001-6885-8538 Therese SeierstadDepartment of Research and Development, Division of Radiology and Nuclear Medicine, Oslo University Hospital, 0424 Oslo, Norway.ORCID 0000-0002-2579-5298 Funding
co-sponsored by Roche Norway and Sanofi-Aventis NorwayK. G. Jebsen Center for Breast Cancer ResearchNorwegian Research Council 191436/V50Pink Ribbon Movement and Norwegian Breast Cancer Society 11003001South-Eastern Norway Regional Health Authority 2021016University of Oslo: Life Science initiative through the convergence environment grant PerCaThe and the European Union's Horizon 2020 Research and Innovation Programme 847912
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
bevacizumabbiomarkersbreast cancermagnetic resonance imagingneoadjuvant therapy
Identifiers
PMID41681863
PMCPMC12897187
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390